by The cell cryopreservation market involves techniques and methods used to freeze and store living cells at very low subzero temperatures, usually -80°C or -196°C in liquid nitrogen. The high preservation of cellular structures and biological activity during the freezing and thawing of cells make cryopreservation an important technology for stem cell therapy, corneal and organ transplantation. Cells that can be stored through cryopreservation include stem cells, hematopoietic stem cells, oocytes, embryos, sperm, and different types of tissues and organs.
The Global Cell Cryopreservation Market is estimated to be valued at US$ 263.58 Bn in 2024 and is expected to exhibit a CAGR of 5.7% over the forecast period from 2024 to 2030.
Key Takeaways
Key players operating in the cell cryopreservation market are BASF, DSM, Kemin Industries, Naturex, Synthite Industries, Aarkay Food Products, Dohler, Sensient Technologies, Vitablend.
The rising number of stem cell therapies and clinical trials, increasing success rate of organ transplants through cryopreserved organs, and growing infertility rates driving demand for sperm, egg, and embryo cryobanking are major opportunities in the market.
Geographic expansion of key players into emerging markets of Asia Pacific, Latin America, and Middle East & Africa through collaborations will boost the availability of cryopreservation technologies in these regions.
Market Drivers
Increasing usage of stem cells in disease treatment and rise in stem cell banking facilities worldwide is a key driver for the cell cryopreservation market. Mesenchymal stem cells owing to their regenerative properties have wide applications in treatment of neurological disorders, cardiovascular diseases, diabetes, and autoimmune conditions. according to World Marrow Donor Association, there were over 37 million stem cell donors registered globally in 2021.
PEST Analysis
Pollical: Regulations around Cell Cryporeservation Market Growth of stem and cord blood cells can impact demand. Different countries have different laws around the use of stem cells.
Economic: The overall health of the global economy influences funding for research areas like regenerative medicine that use cryopreserved cells. During economic downturns research funding may decrease.
Social: As populations age in many countries, demand is growing for procedures like stem cell therapies that use previously cryopreserved cells. Younger generations also expect medical treatments to incorporate latest technological advances.
Technological: Major technological advancements have been made in controlled rate freezing and thawing of cells without damaging them. This has increased the viability of cells after cryopreservation, expanding potential applications. Automation of some aspects has made cryopreservation processes more efficient.
North America currently accounts for the largest share of the cell cryopreservation market in terms of value, due to presence of advanced research infrastructure and increasing investments in regenerative medicine in the region. The Asia Pacific region is projected to be the fastest growing market during the forecast period due to improving healthcare infrastructure, rising medical tourism, and growing research focus on stem cell therapies in countries like China, India, and South Korea.
China in particular is expected to experience rapid growth as the government is strongly supporting research in regenerative medicine and stem cell therapies. Large numbers of ongoing clinical trials in China for conditions like cartilage damage and diabetes seek to demonstrate effectiveness of treatments using cryopreserved cells. This is attracting private sector investments as well to expand local production capacity.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
